🇮🇳India

प्रतिकूल प्रतिक्रिया रिपोर्टिंग में चूक के लिए जुर्माना

2 verified sources

Definition

Mandatory pharmacovigilance under PvPI requires reporting all suspected ADRs for herbal/Ayurvedic medicines to CDSCO. Non-compliance results in fines under Drugs & Cosmetics Act.

Key Findings

  • Financial Impact: ₹5-50 lakhs per violation (statutory fines); 20-40 hours/month manual reporting per clinic
  • Frequency: Per unreported serious ADR; ongoing for high-volume dispensaries
  • Root Cause: Manual documentation delays, lack of standardized PvPI forms, under-reporting of herbal ADRs

Why This Matters

The Pitch: Alternative Medicine players in India waste ₹5-50 lakhs annually on ADR reporting fines and compliance audits. Automation of adverse reaction documentation eliminates this risk.

Affected Stakeholders

Ayurvedic practitioners, Herbal product manufacturers, Clinic owners

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Request Deep Analysis

🇮🇳 Be first to access this market's intelligence